February 7, 2025 · Form 4 insider transaction
Anzalone Christopher Richard bought 9,550 shares of Arrowhead Pharmaceuticals, Inc. at $20.10 per share, a transaction worth $192.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Shares represent equity in lieu of part of his year-end cash bonus.; Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.